NCT02514629View on ClinicalTrials.gov

Testosterone, Metformin, or Both, for Hypogonadism in Obese Males

PHASE3CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

July 4, 2013

Primary Completion Date

July 12, 2016

Study Completion Date

July 12, 2016

Conditions
HypogonadismObesity
Interventions
DRUG

Placebo

DRUG

Metformin

DRUG

Testosterone Undecanoate

DRUG

Metformin + Testosterone Undecanoate

Trial Locations (1)

29010

Hospital Uiversitario Virgen de la Victoria, Málaga

All Listed Sponsors
lead

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

OTHER

NCT02514629 - Testosterone, Metformin, or Both, for Hypogonadism in Obese Males | Biotech Hunter | Biotech Hunter